1. Home
  2. PARR vs VERA Comparison

PARR vs VERA Comparison

Compare PARR & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Par Pacific Holdings Inc.

PARR

Par Pacific Holdings Inc.

HOLD

Current Price

$64.39

Market Cap

3.2B

Sector

Energy

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$40.71

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PARR
VERA
Founded
1984
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.9B
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
PARR
VERA
Price
$64.39
$40.71
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$57.00
$81.30
AVG Volume (30 Days)
1.5M
1.0M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
1313.56
N/A
EPS
7.16
N/A
Revenue
$2,443,066,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.73
$416.83
P/E Ratio
$9.06
N/A
Revenue Growth
30.99
N/A
52 Week Low
$12.17
$18.53
52 Week High
$66.75
$56.05

Technical Indicators

Market Signals
Indicator
PARR
VERA
Relative Strength Index (RSI) 68.95 51.22
Support Level $34.55 $37.36
Resistance Level N/A $42.73
Average True Range (ATR) 3.57 2.05
MACD 0.18 0.21
Stochastic Oscillator 87.18 62.68

Price Performance

Historical Comparison
PARR
VERA

About PARR Par Pacific Holdings Inc.

Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments: Refining. Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operating licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: